Literature DB >> 20634409

Distribution of the feline calicivirus receptor junctional adhesion molecule a in feline tissues.

P A Pesavento1, T Stokol, H Liu, D A van der List, P M Gaffney, J S Parker.   

Abstract

Junctional adhesion molecule A (JAM-A) is an immunoglobulin superfamily protein that plays an important role in the assembly and maintenance of tight junctions and the establishment of epithelial cell polarity. The feline JAM-A (fJAM-A) is a functional receptor for feline calicivirus (FCV). Among natural diseases associated with FCV infection, isolates that cause oral vesicular disease are detected in epithelial cells; however, isolates that cause systemic disease are detected in multiple cell types. The distribution of an FCV receptor or receptors in feline tissues is relevant to viral pathogenesis in that it should reflect the wide latitude of clinical sequelae associated with FCV infection. The authors examined the expression of feline JAM-A in the cat by using confocal immunofluorescence localization on normal tissues, with special regard to tissue targets of naturally occurring FCV. As described in the human and the mouse, fJAM-A was widely distributed in feline tissues, where it localized at cell-cell junctions of epithelial and endothelial cells. fJAM-A was highly expressed on feline platelets, with lower levels of expression on feline peripheral blood leukocytes. Additionally, FCV infection of a feline epithelial cell monolayer causes redistribution of fJAM-A to the cytosol of infected cells. It is reasonable to propose that the spectrum of lesions caused by FCV reflects disruption of intercellular junctions that rely on fJAM-A function and tight junctional integrity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634409     DOI: 10.1177/0300985810375245

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  5 in total

Review 1.  Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus.

Authors:  Vera Kemp; Rob C Hoeben; Diana J M van den Wollenberg
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

2.  Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitro.

Authors:  Zhanding Cui; Dengliang Li; Yinli Xie; Kai Wang; Ying Zhang; Guohua Li; Qian Zhang; Xiaoxueying Chen; Yue Teng; Shihui Zhao; Jiang Shao; Fan Xingmeng; Yanli Zhao; Dongju Du; Yanbing Guo; Hailong Huang; Hao Dong; Guixue Hu; Shuang Zhang; Yongkun Zhao
Journal:  Antiviral Res       Date:  2020-06-21       Impact factor: 5.970

Review 3.  Immune Response Modulation by Caliciviruses.

Authors:  Yoatzin Peñaflor-Téllez; Adrian Trujillo-Uscanga; Jesús Alejandro Escobar-Almazán; Ana Lorena Gutiérrez-Escolano
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

4.  Equine immunoglobulin F(ab')2 fragments protect cats against feline calicivirus infection.

Authors:  Zhanding Cui; Dengliang Li; Shushuai Yi; Yanbing Guo; Guoying Dong; Jiangting Niu; Han Zhao; Ying Zhang; Shengnan Zhang; Lili Cao; Kai Wang; Yongkun Zhao; Guixue Hu
Journal:  Int Immunopharmacol       Date:  2019-07-25       Impact factor: 4.932

5.  Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.

Authors:  Andrea M Spiri; Barbara Riond; Martina Stirn; Marilisa Novacco; Marina L Meli; Felicitas S Boretti; Imogen Herbert; Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2021-07-30       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.